v3.25.2
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2025
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement During the quarterly period covered by this report, our directors and officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) adopted, terminated or modified the Rule 10b5-1 trading arrangements (as defined in Item 408 of Regulation S-K) set forth in the table below. No non-Rule 10b5-1 trading arrangements were adopted, modified or terminated by any director or officer during the quarterly period covered by this report.
    
NameTitleType of Trading ArrangementSecurityActionDate of ActionDuration of Trading ArrangementAggregate Number of Securities Covered
Karthik KuppusamySVP, Clinical SolutionsRule 10b5-1 plan to sellCommon StockAdoptionMay 1, 2025
May 1, 2025 to October 31, 2025*
Up to 10,479*
Patrick PlewmanSVP, Diagnostic ServicesRule 10b5-1 plan to sellCommon StockAdoptionMay 1, 2025
May 1, 2025 to March 31, 2026*
Up to 48,470*
Michael PrevoznikSVP, General CounselRule 10b5-1 plan to sellCommon StockAdoptionMay 30, 2025
May 30, 2025 to March 31, 2026*
Up to 35,962*

    * Includes shares of common stock to be released from (a) restricted stock units that are expected to vest and (b) performance share awards that may vest, subject to the satisfaction of the applicable performance metrics. The actual number of shares of common stock that will be released is not yet determinable and the actual number of shares of common stock that will be sold will be net of the number of shares withheld to satisfy tax withholding obligations.
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Patrick Plewman [Member]  
Trading Arrangements, by Individual  
Name Patrick Plewman
Title SVP, Diagnostic Services
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 1, 2025
Expiration Date March 31, 2026
Arrangement Duration 334 days
Aggregate Available 48,470
Michael Prevoznik [Member]  
Trading Arrangements, by Individual  
Name Michael Prevoznik
Title SVP, General Counsel
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 30, 2025
Expiration Date March 31, 2026
Arrangement Duration 305 days
Aggregate Available 35,962
Karthik Kuppusamy [Member]  
Trading Arrangements, by Individual  
Name Karthik Kuppusamy
Title SVP, Clinical Solutions
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 1, 2025
Expiration Date October 31, 2025
Arrangement Duration 183 days
Aggregate Available 10,479